Taieb, Julien http://orcid.org/0000-0002-9955-4753
Jung, Andreas
Sartore-Bianchi, Andrea http://orcid.org/0000-0003-0780-0409
Peeters, Marc
Seligmann, Jenny
Zaanan, Aziz
Burdon, Peter http://orcid.org/0000-0002-7528-025X
Montagut, Clara
Laurent-Puig, Pierre http://orcid.org/0000-0001-8475-5459
Funding for this research was provided by:
Amgen (Europe) GmbH
Article History
First Online: 25 July 2019
Compliance with Ethical Standards
:
: Medical writing support was funded by Amgen (Europe) GmbH.
: Julien Taieb has acted in consultancy and/or advisory roles for, and received honoraria from, Amgen, Celgene, Lilly, Merck, MSD, Roche, Sanofi, Servier and Sirtex. Andreas Jung has acted in advisory roles for, and received honoraria and travel support from, Amgen, AstraZeneca, Biocartis, Boehringer Ingelheim, Bristol-Myers Squibb, Merck, Novartis and Roche. Andrea Sartore-Bianchi has acted in consultancy and/or advisory roles for, and received honoraria from, Amgen, Bayer, Lilly and Sanofi. Marc Peeters has received research funding from Amgen and Roche, and honoraria from Amgen, Lilly, Merck Serono, Remedus, Roche, Sanofi-Aventis, Servier, Sirtex and Terumo. Jenny Seligmann has acted in an advisory role for Roche and received honoraria from Merck Serono. Aziz Zaanan has acted in consultancy and/or advisory roles for Amgen, Baxter, Lilly, Merck Serono, MSD, Roche, Sanofi and Servier. Peter Burdon is an employee of Amgen (Europe) GmbH and owns shares in Amgen. Clara Montagut has acted in consultancy and/or advisory roles for Amgen, Merck Serono, Roche, Sanofi-Aventis, Servier and Symphogen, and received research funding from Amgen, Merck Serono and Symphogen. Pierre Laurent-Puig has acted in consultancy and/or advisory roles for Amgen, Biocartis, Boehringer Ingelheim, Bristol-Myers Squibb, Lilly, MDS, Merck Serono, Roche, Sanofi, and holds a patent for miR-31-3p.
: All information generated as part of the literature review for this paper has been included in the publication.